Terns Pharmaceuticals, Inc. (FRA:430)
Germany flag Germany · Delayed Price · Currency is EUR
30.00
-2.00 (-6.25%)
At close: Jan 9, 2026

Terns Pharmaceuticals Statistics

Total Valuation

FRA:430 has a market cap or net worth of EUR 3.32 billion. The enterprise value is 3.06 billion.

Market Cap3.32B
Enterprise Value 3.06B

Important Dates

The next estimated earnings date is Monday, March 23, 2026.

Earnings Date Mar 23, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 108.77M
Shares Outstanding n/a
Shares Change (YoY) +22.42%
Shares Change (QoQ) +0.14%
Owned by Insiders (%) 0.31%
Owned by Institutions (%) 52.88%
Float 80.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 13.70
P/TBV Ratio 13.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -38.07
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.52, with a Debt / Equity ratio of 0.00.

Current Ratio 19.52
Quick Ratio 19.21
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -29.12% and return on invested capital (ROIC) is -20.83%.

Return on Equity (ROE) -29.12%
Return on Assets (ROA) -19.94%
Return on Invested Capital (ROIC) -20.83%
Return on Capital Employed (ROCE) -37.89%
Revenue Per Employee n/a
Profits Per Employee -1.36M
Employee Count59
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, FRA:430 has paid 202,847 in taxes.

Income Tax 202,847
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 121

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.16

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -92.45M
Pretax Income -80.28M
Net Income -80.49M
EBITDA -92.33M
EBIT -92.45M
Earnings Per Share (EPS) -0.88
Full Income Statement

Balance Sheet

The company has 251.97 million in cash and 877,017 in debt, with a net cash position of 251.09 million.

Cash & Cash Equivalents 251.97M
Total Debt 877,017
Net Cash 251.09M
Net Cash Per Share n/a
Equity (Book Value) 242.11M
Book Value Per Share 2.77
Working Capital 242.83M
Full Balance Sheet

Cash Flow

Operating Cash Flow -66.20M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

FRA:430 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.42%
Shareholder Yield -22.42%
Earnings Yield -2.43%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1